Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCILLA: Azathioprine vs Infliximab for Maintenance of Remission in Ulcerative Colitis
NCT03151525Phase 4Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- May 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azathioprine in ulcerative colitis (UC) (2 arms), sponsored by Humanitas Research Hospital. Primary endpoint: Relapse rate at 12 months. Status: unknown.
02
Drugs
azathioprine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03151525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151525.